Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1976 Sep;125(3):181–186.

Role of Platelets in Hemostasis and Thrombosis

Robert Rodvien 1,2,3,4, C Harold Mielke Jr 1,2,3,4
PMCID: PMC1237260  PMID: 969503

Abstract

Platelets interact with the coagulation factors in a complex way to arrest bleeding or generate thrombi. Recently, the platelet's relationship to endothelial alteration and atheroma production has received renewed attention. At present, tests of platelet function better define “hypocoagulable” rather than “hypercoagulable” states.

Full text

PDF
184

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIGGS R., MACFARLANE R. G., DENSON K. W., ASH B. J. THROMBIN AND THE INTERACTION OF FACTORS 8 AND 9. Br J Haematol. 1965 May;11:276–295. doi: 10.1111/j.1365-2141.1965.tb06588.x. [DOI] [PubMed] [Google Scholar]
  2. BORN G. V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962 Jun 9;194:927–929. doi: 10.1038/194927b0. [DOI] [PubMed] [Google Scholar]
  3. Chandra S., Triantaphyllopoulos D. C. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin. Thromb Diath Haemorrh. 1973 Nov;30(2):235–247. [PubMed] [Google Scholar]
  4. Cooley M. H., Cohen P. Plasma acid phosphatase in idiopathic and secondary thrombocytopenias. Arch Intern Med. 1967 Apr;119(4):345–354. [PubMed] [Google Scholar]
  5. Deykin D. Emerging concepts of platelet function. N Engl J Med. 1974 Jan 17;290(3):144–151. doi: 10.1056/NEJM197401172900308. [DOI] [PubMed] [Google Scholar]
  6. Feinman R. D., Detwiler T. C. Letter to the editors-in-chief: Absence of a requirement for extracellular calcium for secretion from platelets. Thromb Res. 1975 Oct;7(4):677–679. doi: 10.1016/0049-3848(75)90113-9. [DOI] [PubMed] [Google Scholar]
  7. GAARDER A., JONSEN J., LALAND S., HELLEM A., OWREN P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature. 1961 Nov 11;192:531–532. doi: 10.1038/192531a0. [DOI] [PubMed] [Google Scholar]
  8. Genton E., Gent M., Hirsh J., Harker L. A. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts). N Engl J Med. 1975 Dec 18;293(25):1296–1300. doi: 10.1056/NEJM197512182932506. [DOI] [PubMed] [Google Scholar]
  9. Gresham G. A. Early events in atherogenesis. Lancet. 1975 Mar 15;1(7907):614–615. doi: 10.1016/s0140-6736(75)91889-9. [DOI] [PubMed] [Google Scholar]
  10. HENRY R. L. LEUKOCYTES AND THROMBOSIS. Thromb Diath Haemorrh. 1965 Mar 15;13:35–46. [PubMed] [Google Scholar]
  11. HENRY R. L. LEUKOCYTES AND THROMBOSIS. Thromb Diath Haemorrh. 1965 Mar 15;13:35–46. [PubMed] [Google Scholar]
  12. Hamberg M., Svensson J., Samuelsson B. Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proc Natl Acad Sci U S A. 1974 Oct;71(10):3824–3828. doi: 10.1073/pnas.71.10.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Han P., Ardlie N. G. Platelet aggregation and release by ADP and thrombin: evidence for two separate effects of ADP on platelets, involvement of fibrinogen in release, and mechanism of inhibitory action of acetylsalicylic acid. Br J Haematol. 1974 Mar;26(3):357–372. doi: 10.1111/j.1365-2141.1974.tb00478.x. [DOI] [PubMed] [Google Scholar]
  14. Harker L. A. Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol. 1970 Jul;19(1):95–104. doi: 10.1111/j.1365-2141.1970.tb01605.x. [DOI] [PubMed] [Google Scholar]
  15. Kaneshiro M. M., Mielke C. H., Jr, Kasper C. K., Rapaport S. I. Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med. 1969 Nov 6;281(19):1039–1042. doi: 10.1056/NEJM196911062811904. [DOI] [PubMed] [Google Scholar]
  16. Ludlam C. A., Bolton A. E., Moore S., Cash J. D. New rapid method for diagnosis of deep venous thrombosis. Lancet. 1975 Aug 9;2(7928):259–260. doi: 10.1016/s0140-6736(75)90967-8. [DOI] [PubMed] [Google Scholar]
  17. MARCUS A. J., ULLMAN H. L., SAFIER L. B., BALLARD H. S. Platelet phosphatides. Their fatty acid and aldehyde composition and activity in different clotting systems. J Clin Invest. 1962 Dec;41:2198–2212. doi: 10.1172/JCI104679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Macfarlane D. E., Walsh P. N., Mills D. C., Holmsen H., Day H. J. The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation. Br J Haematol. 1975 Aug;30(4):457–463. doi: 10.1111/j.1365-2141.1975.tb01860.x. [DOI] [PubMed] [Google Scholar]
  19. Malmsten C., Hamberg M., Svensson J., Samuelsson B. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1446–1450. doi: 10.1073/pnas.72.4.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Marcus A. J., Zucker-Franklin D., Safier L. B., Ullman H. L. Studies on human platelet granules and membranes. J Clin Invest. 1966 Jan;45(1):14–28. doi: 10.1172/JCI105318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Massini P., Lüscher E. F. Some effects of ionophores for divalent cations on blood platelets. Comparison with the effects of thrombin. Biochim Biophys Acta. 1974 Nov 4;372(1):109–121. doi: 10.1016/0304-4165(74)90077-4. [DOI] [PubMed] [Google Scholar]
  22. Mielke C. H., Jr, Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969 Aug;34(2):204–215. [PubMed] [Google Scholar]
  23. Mustard J. F., Packham M. A. Platelets, thrombosis and drugs. Drugs. 1975;9(1):19–76. doi: 10.2165/00003495-197509010-00003. [DOI] [PubMed] [Google Scholar]
  24. Paulus J. M. Platelet size in man. Blood. 1975 Sep;46(3):321–336. [PubMed] [Google Scholar]
  25. Rosoff C. B., Salzman E. W., Gurewich V. Reduction of platelet serotonin and the response to pulmonary emboli. Surgery. 1971 Jul;70(1):12–19. [PubMed] [Google Scholar]
  26. Salzman E. W. Cyclic AMP and platelet function. N Engl J Med. 1972 Feb 17;286(7):358–363. doi: 10.1056/NEJM197202172860708. [DOI] [PubMed] [Google Scholar]
  27. Salzman E. W., Kensler P. C., Levine L. Cyclic 3',5'-adenosine monophosphate in human blood platelets. IV. Regulatory role of cyclic amp in platelet function. Ann N Y Acad Sci. 1972 Oct 27;201:61–71. doi: 10.1111/j.1749-6632.1972.tb16287.x. [DOI] [PubMed] [Google Scholar]
  28. Salzman E. W., Lindon J. N., Rodvien R. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact. J Cyclic Nucleotide Res. 1976;2(1):25–37. [PubMed] [Google Scholar]
  29. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  30. Stuart M. J., Murphy S., Oski F. A. A simple nonradioisotope technic for the determination of platelet life-span. N Engl J Med. 1975 Jun 19;292(25):1310–1313. doi: 10.1056/NEJM197506192922502. [DOI] [PubMed] [Google Scholar]
  31. Thomas D. P., Gurewich V., Ashford T. P. Platelet adherence to thromboemboli in relation to the pathogenesis and treatment of pulmonary embolism. N Engl J Med. 1966 Apr 28;274(17):953–956. doi: 10.1056/NEJM196604282741709. [DOI] [PubMed] [Google Scholar]
  32. Tollefsen D. M., Feagler J. R., Majerus P. W. The binding of thrombin to the surface of human platelets. J Biol Chem. 1974 Apr 25;249(8):2646–2651. [PubMed] [Google Scholar]
  33. Walsh P. N. Platelet coagulant activities and hemostasis: a hypothesis. Blood. 1974 Apr;43(4):597–605. [PubMed] [Google Scholar]
  34. Walsh P. N. Platelet coagulant activities: evidence for multiple different functions of platelets in intrinsic coagulation. Ser Haematol. 1973;6(4):579–592. [PubMed] [Google Scholar]
  35. Weiss H. J. Platelet physiology and abnormalities of platelet function (second of two parts). N Engl J Med. 1975 Sep 18;293(12):580–588. doi: 10.1056/NEJM197509182931204. [DOI] [PubMed] [Google Scholar]
  36. Weksler B. B., Coupal C. E. Platelet-dependent generation of chemotactic activity in serum. J Exp Med. 1973 Jun 1;137(6):1419–1430. doi: 10.1084/jem.137.6.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Willis A. L., Vane F. M., Kuhn D. C., Scott C. G., Petrin M. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins. 1974 Dec 25;8(6):453–507. doi: 10.1016/0090-6980(74)90062-8. [DOI] [PubMed] [Google Scholar]
  38. Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet. 1974 Oct 19;2(7886):924–926. doi: 10.1016/s0140-6736(74)91131-3. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES